Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced the launch of renowned European skin-remodeling brand, Profhilo, in India, offering a new breakthrough approach in skin anti-ageing. Profhilo, developed by the international pharma company, IBSA, created a new concept of ‘Bioremodeling’ in the dermal injectables industry, offering an overarching approach to skin ageing, beyond currently available solutions.
As we age, production of collagen and elastin, the proteins responsible for skin elasticity and firmness, slows down, resulting in skin laxity and sagging skin. Profhilo delivers a high concentration of pure Hyaluronic acid to different layers of the skin, promoting the multilevel and dynamic remodeling of extracellular matrix in terms of elasticity and support, while maintaining the viability of fibroblast, keratinocytes, and adipocytes to provide deep hydration and rejuvenation of the skin tissue. With 64 MG of hyaluronic acid per syringe, Profhilo delivers the highest concentration of this compound to the skin as compared to other HA-based treatments.